You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
信達生物(01801.HK)完成配售5620萬股 淨籌27.88億港元
格隆匯 07-30 22:28

格隆匯 7 月 30日丨信達生物(01801.HK)宣佈,一級配售的完成已於2020年7月30日發生。合共5620萬股一級配售股份已由獨家配售代理根據一級配售協議的條款及條件成功配售予不少於六名承配人,配售價為每股股份50.00港元。一級配售的所得款項淨額約為27.88億港元。

董事會已獲(i)俞博士及Yu女士(作為Yu Tong Family Irrevocable Trust的受託人)及(ii)Capital International Vendors告知,二級配售的完成已於2020年7月27日發生。根據二級配售協議的條款及條件,獨家配售代理已成功促使買方按配售價每股股份50.00港元購買(i)800萬股代表俞博士的二級配售股份;(ii)100萬股代表Yu女士(作為Yu Tong Family Irrevocable Trust的受託人)的二級配售股份;及(iii)2780萬股代表Capital International Vendors的二級配售股份。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account